ERBB2 and breast cancer: The tumors in the lowest quartile group were significantly associated with estrogen-negative receptor staining, high grade and the Luminal B and ERBB2 breast cancer subtypes, while tumors in the two middle quartiles showed significant association with a high fraction to estrogen receptor positive tumors, low grade and tumors of the Luminal A subtype.